Developer of a precision pharmacology platform designed for creating innovative therapies for central nervous system diseases. The company's platform leverages human genetics and machine learning to identify and validate drug targets, enabling medical professionals to deliver safe and more productive therapies for patients with neurological disorders.
linkedin.comPart of: Brex Recap: SF Startups 2024